olprinone has been researched along with Multiple Organ Failure in 1 studies
olprinone: RN refers to HCl; structure given in first source
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with olprinone attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan." | 1.37 | Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice. ( Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzon, E | 1 |
| Esposito, E | 1 |
| Di Paola, R | 1 |
| Impellizzeri, D | 1 |
| Bramanti, P | 1 |
| Cuzzocrea, S | 1 |
1 other study available for olprinone and Multiple Organ Failure
| Article | Year |
|---|---|
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Apoptosis; Ascitic Fluid; Aspartate A | 2011 |